Transfusion requirements in surgical oncology patients: A prospective, randomized controlled trial

Anesthesiology

Volumn 122, Issue 1, 2015, Pages 29-38

  De Almeida, Juliano Pinheiro ^a   Vincent, Jean Louis ^b   Galas, Filomena Regina Barbosa Gomes ^a   De Almeida, Elisangela Pinto Marinho ^a   Fukushima, Julia T ^a   Osawa, Eduardo A ^a   Bergamin, Fabricio ^a   Park, Clarice Lee ^a   Nakamura, Rosana Ely ^a   Fonseca, Silvia M R ^a   Cutait, Guilherme ^a   Alves, Joseane Inacio ^a   Bazan, Mellik ^a   Vieira, Silvia ^a   Sandrini, Ana C Vieira ^a   Palomba, Henrique ^a   Ribeiro, Ulysses ^a   Crippa, Alexandre ^a,c   Dalloglio, Marcos ^a   Del Pilar Estevez Diz, Maria ^a   Filho, Roberto Kalil ^a   Auler, Jose Otavio Costa ^a   Rhodes, Andrew ^a   Hajjar, Ludhmila Abrahao ^a   more..

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b ERASME HOSPITAL   (Belgium)

^c ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; ABDOMINAL SURGERY; ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; CANCER SURGERY; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; INTENSIVE CARE; LIBERAL ERYTHROCYTE TRANSFUSION; MAJOR CLINICAL STUDY; MAJOR SURGERY; MALE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; RESPIRATORY FAILURE; RESTRICTIVE ERYTHROCYTE TRANSFUSION; RISK REDUCTION; SEPTIC SHOCK; ABDOMINAL NEOPLASMS; BRAZIL; FOLLOW UP; INTENSIVE CARE UNIT; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; PROCEDURES; RISK; STATISTICS AND NUMERICAL DATA;

HEMOGLOBIN;

ABDOMINAL NEOPLASMS; BRAZIL; DOUBLE-BLIND METHOD; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK;

EID: 84925356457     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/aln.0000000000000511     Document Type: Article

References (33)

1. Law S, Wong KH, Kwok KF, Chu KM, Wong J: Predictive factors for postoperative pulmonary complications and mortality after esophagectomy for cancer. Ann Surg 2004; 240: 791-800
2. Masoomi H, Kang CY, Chen A, Mills S, Dolich MO, Carmichael JC, Stamos MJ: Predictive factors of in-hospital mortality in colon and rectal surgery. J Am Coll Surg 2012; 215: 255-61
3. Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A; European Surgical Outcomes Study (EuSOS) Group for the Trials Groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology: Mortality after surgery in Europe: A 7 day cohort study. Lancet 2012; 380: 1059-65
4. Weber RS, Jabbour N, Martin RC II: Anemia and transfusions in patients undergoing surgery for cancer. Ann Surg Oncol 2008; 15: 34-45
5. Acheson AG, Brookes MJ, Spahn DR: Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: A systematic review and meta-analysis. Ann Surg 2012; 256: 235-44
6. Dicato M, Plawny L, Diederich M: Anemia in cancer. Ann Oncol 2010; 21(suppl 7): Vii167-72
7. Koch M, Antolovic D, Reissfelder C, Rahbari NN, Holoch J, Michalski I, Sweiti H, Ulrich A, Büchler MW, Weitz J: Leucocyte-depleted blood transfusion is an independent predictor of surgical morbidity in patients undergoing elective colon cancer surgery-A single-center analysis of 531 patients. Ann Surg Oncol 2011; 18: 1404-11
8. Amato A, Pescatori M: Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006;CD005033
9. Vamvakas EC, Blajchman MA: Deleterious clinical effects of transfusion-associated immunomodulation: Fact or fiction? Blood 2001; 97: 1180-95
10. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, Tweeddale M, Schweitzer I, Yetisir E: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-17
11. Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984; 2: 187-93
12. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-55
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-83
14. Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction: Universal definition of myocardial infarction. J Am Coll Cardiol 2007; 50: 2173-95
15. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G; SCCM/ESICM/ACCP/ATS/SIS: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-6
16. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P; Acute Dialysis Quality Initiative workgroup: Acute renal failure-Definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-12
17. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149(3 Pt 1): 818-24
18. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED: Early goal-directed therapy after major surgery reduces complications and duration of hospital stay. A randomised, controlled trial [ISRCTN38797445]. Crit Care 2005; 9: R687-93
19. Hajjar LA, Vincent JL, Galas FR, Nakamura RE, Silva CM, Santos MH, Fukushima J, Kalil Filho R, Sierra DB, Lopes NH, Mauad T, Roquim AC, Sundin MR, Leão WC, Almeida JP, Pomerantzeff PM, Dallan LO, Jatene FB, Stolf NA, Auler JO Jr: Transfusion Requirements After Cardiac Surgery: The TRACS randomized controlled trial. JAMA 2010; 304: 1559-67
20. Carson JL, Terrin ML, Noveck H, Sanders DW, Chaitman BR, Rhoads GG, Nemo G, Dragert K, Beaupre L, Hildebrand K, Macaulay W, Lewis C, Cook DR, Dobbin G, Zakriya KJ, Apple FS, Horney RA, Magaziner J; FOCUS Investigators: Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-62
21. Sakr Y, Lobo S, Knuepfer S, Esser E, Bauer M, Settmacher U, Barz D, Reinhart K: Anemia and blood transfusion in a surgical intensive care unit. Crit Care 2010; 14: R92
22. Jhanji S, Vivian-Smith A, Lucena-Amaro S, Watson D, Hinds CJ, Pearse RM: Haemodynamic optimisation improves tissue microvascular flow and oxygenation after major surgery: A randomised controlled trial. Crit Care 2010; 14: R151
23. Weinberg JA, MacLennan PA, Vandromme-Cusick MJ, Angotti JM, Magnotti LJ, Kerby JD, Rue LW III, Barnum SR, Patel RP: Microvascular response to red blood cell transfusion in trauma patients. Shock 2012; 37: 276-81
24. Flancbaum L, Ziegler DW, Choban PS: Preoperative intensive care unit admission and hemodynamic monitoring in patients scheduled for major elective noncardiac surgery: A retrospective review of 95 patients. J Cardiothorac Vasc Anesth 1998; 12: 3-9
25. Lobo SM, Salgado PF, Castillo VG, Borim AA, Polachini CA, Palchetti JC, Brienzi SL, de Oliveira GG: Effects of maximizing oxygen delivery on morbidity and mortality in high-risk surgical patients. Crit Care Med 2000; 28: 3396-404
26. Pearse R, Dawson D, Fawcett J, Rhodes A, Grounds RM, Bennett ED: Changes in central venous saturation after major surgery, and association with outcome. Crit Care 2005; 9: R694-9
27. Pearse RM, Belsey JD, Cole JN, Bennett ED: Effect of dopexamine infusion on mortality following major surgery: Individual patient data meta-regression analysis of published clinical trials. Crit Care Med 2008; 36: 1323-9
28. Sakr Y, Chierego M, Piagnerelli M, Verdant C, Dubois MJ, Koch M, Creteur J, Gullo A, Vincent JL, De Backer D: Microvascular response to red blood cell transfusion in patients with severe sepsis. Crit Care Med 2007; 35: 1639-44
29. Carson JL, Duff A, Poses RM, Berlin JA, Spence RK, Trout R, Noveck H, Strom BL: Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet 1996; 348: 1055-60
30. Carson JL, Noveck H, Berlin JA, Gould SA: Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002; 42: 812-8
31. Wu WC, Schifftner TL, Henderson WG, Eaton CB, Poses RM, Uttley G, Sharma SC, Vezeridis M, Khuri SF, Friedmann PD: Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA 2007; 297: 2481-8
32. Park DW, Chun BC, Kwon SS, Yoon YK, Choi WS, Sohn JW, Peck KR, Kim YS, Choi YH, Choi JY, Kim SI, Eom JS, Kim HY, Cheong HJ, Song YG, Choi HJ, Kim JM, Kim MJ: Red blood cell transfusions are associated with lower mortality in patients with severe sepsis and septic shock: A propensitymatched analysis. Crit Care Med 2012; 40: 3140-5
33. Soares M, Caruso P, Silva E, Teles JM, Lobo SM, Friedman G, Dal Pizzol F, Mello PV, Bozza FA, Silva UV, Torelly AP, Knibel MF, Rezende E, Netto JJ, Piras C, Castro A, Ferreira BS, Réa-Neto A, Olmedo PB, Salluh JI; Brazilian Research in Intensive Care Network (BRICNet): Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study. Crit Care Med 2010; 38: 9-15